Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Kishor SURYAWANSHI"'
Autor:
Suresh B. Patankar, Anupama Gorde, Kalpana Joshi, Kishor Suryawanshi, Pravin Soni, Tejas Shah, Sagar Patankar, Diwakar Jha, Rajesh Raje, Hrishikesh Rangnekar
Publikováno v:
Journal of Ayurveda and Integrative Medicine, Vol 13, Iss 4, Pp 100653- (2022)
Background: Novel corona virus disease-2019 (COVID-19) pandemic is a significant contributor to morbidity and mortality in affected individuals. Modulating the immune response in COVID-19 is now an established treatment approach. Polyherbal formulati
Externí odkaz:
https://doaj.org/article/a0e06068f2484d3898ac2e37e8c96c6e
Publikováno v:
Türk Patoloji Dergisi, Vol 33, Iss 1, Pp 74-76 (2017)
Congenital lobar emphysema is a one of the rare variety of congenital abnormality of the lung causing respiratory distress in newborns and infants. Herein, we report a case of congenital lobar emphysema in a 3-week-old female admitted to the pediatri
Externí odkaz:
https://doaj.org/article/5c8f488efe1648f69afbe22e882a6c9f
Publikováno v:
Online Journal of Health & Allied Sciences, Vol 12, Iss 3 (2013)
Giant cell tumours (GCTs) of bone have been described as the most challenging benign bone tumors. It is very unusual for GCT to occur in patients younger than 20 yrs or older than 55 years. GCT is seen with a slightly increased frequency in females.
Externí odkaz:
https://doaj.org/article/8674f50ad8b84a3392ec6a6573b6f870
Autor:
Suresh B. Patankar, Anupama Gorde, Kalpana Joshi, Kishor Suryawanshi, Pravin Soni, Tejas Shah, Sagar Patankar, Diwakar Jha, Rajesh Raje, Hrishikesh Rangnekar
Publikováno v:
Journal of Ayurveda and integrative medicine. 13(4)
Novel corona virus disease-2019 (COVID-19) pandemic is a significant contributor to morbidity and mortality in affected individuals. Modulating the immune response in COVID-19 is now an established treatment approach. Polyherbal formulations have lon
Autor:
Suresh Balkrishna Patankar, Sagar Patankar, Anupama Gorde, Pravin Soni, Hrishikesh Rangnekar, Kishor Suryawanshi, Diwakar Jha, Rajesh Raje, Tejas Shah, Kalpana Joshi
ObjectiveTo assess the efficacy and safety of polyherbal formulation (designated as IP) in comparison to placebo as add on to the standard of care (SoC) among patients with mild to moderate novel corona virus disease 2019 (COVID-19)MethodsLaboratory
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::114a3ec709bbd83e87cef5299e0e51c6
https://doi.org/10.1101/2021.05.14.21256900
https://doi.org/10.1101/2021.05.14.21256900
Publikováno v:
INTERNATIONAL JOURNAL OF SCIENTIFIC RESEARCH. :48-49
Soft Tissue Sarcomas (STS) are rare tumours with dismal prognosis. Undifferentiated Pleomorphic Sarcoma (UPS) was formerly called Malignant Fibrous Histiocytoma (MFH) and reclassied by the World Health Organization (WHO) in 2013. UPS account for 5
Publikováno v:
Trials
Objectives Primary Objective • To assess the efficacy of herbal extracts in boosting innate immunity of patients with COVID-19 infection. Secondary Objectives • To assess the efficacy of herbal extracts in restoring respiratory health • To asse